Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Conditions
- Neurocognitive
- Neuroprotective
- Neonatal
- Neurodevelopmental Impairment
Interventions
- DRUG: Darbepoetin
- DRUG: Placebo
Sponsor
NICHD Neonatal Research Network
Collaborators